ALTESA

altesa-logo

Altesa is a clinical-stage biopharmaceutical company dedicated to accelerating the development of new treatments against age-old threats to human health: high-consequence viral pathogens.

#SimilarOrganizations #People #Website #More

ALTESA

Social Links:

Industry:
Biotechnology Life Science Therapeutics

Founded:
2022-01-01

Address:
College Park, Georgia, United States

Country:
United States

Website Url:
http://www.altesabio.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
35 M USD


Similar Organizations

aclaris-therapeutics-logo

Aclaris Therapeutics

Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.

carisma-therapeutics-logo

Carisma Therapeutics

Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

nivalis-therapeutics-logo

Nivalis Therapeutics

Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.

precision-for-medicine-logo

Precision For Medicine

Precision for Medicine is the first global, precision-medicine, clinical research organization.

renovacor-logo

Renovacor

Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapyโ€‘based treatments for cardiovascular disease.

tcr2-logo

TCR2

TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuCโ„ข platform.

Current Employees Featured

seth-rudnick_image

Seth Rudnick
Seth Rudnick Co-Founder @ Altesa
Co-Founder

george-painter_image

George Painter
George Painter Co-Founder, President and CEO @ Altesa
Co-Founder, President and CEO

Founder


george-painter_image

George Painter

seth-rudnick_image

Seth Rudnick

Official Site Inspections

http://www.altesabio.com

  • Host name: ec2-3-217-116-166.compute-1.amazonaws.com
  • IP address: 3.217.116.166
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Altesa"

Home - Altesa BioSciences

Altesa is a clinical-stage pharmaceutical company dedicated to developing new treatments for age-old threats to human health: high-consequence viral infections. These infections are particularly severe in vulnerable people, including those โ€ฆSee details»

Leadership - Altesa BioSciences

Our leadership team is a highly successful and uniquely experienced group of clinicians, scientists, corporate executives, and investment professionals. Our focus: deliver novel โ€ฆSee details»

Leadership - altesabio.com

Erica specializes in employee relations, employee engagement, and HR compliance. She believes that the employee experience correlates with the success of the organization; โ€ฆSee details»

Altesa - Crunchbase Company Profile & Funding

Altesa is a clinical-stage biopharmaceutical company dedicated to accelerating the development of new treatmentsSee details»

Altesa BioSciences, Inc. | LinkedIn

Altesa BioSciences, Inc. | 694 followers on LinkedIn. Developing antivirals for diseases of global concernSee details»

Altesa Biosciences - VentureRadar

Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and โ€ฆSee details»

Altesa BioSciences Announces Scientific Advisory Board

Feb 28, 2022 Altesa BioSciences, Inc., a clinical-stage biopharmaceutical company developing and commercializing novel anti-viral drugs against common respiratory viruses and global viral โ€ฆSee details»

Leadership - Altesa Bio

Altesa.com John M. Clerici, JD is a co-founder and Chief Operating Oficer of Altesa. As the founding Principal of Tiber Creek Partners, LLC, John has been a leader in public health โ€ฆSee details»

Altesa BioSciences - PitchBook

Mar 21, 2022 Information on valuation, funding, cap tables, investors, and executives for Altesa BioSciences. Use the PitchBook Platform to explore the full profile.See details»

Overview, News & Similar companies - ZoomInfo.com

May 24, 2022 View Altesa BioSciences (www.altesabio.com) location in Georgia, United States , revenue, industry and description. Find related and similar companies as well as employees โ€ฆSee details»

Altesa BioSciences, Inc., Launches Operations to Develop

Feb 10, 2022 Altesa BioSciences, Inc., an independently operated, for-profit biotechnology company today launched operations to develop and commercialize novel anti-viral drugs โ€ฆSee details»

Altesa BioSciences Announces Scientific Advisory Board

Feb 28, 2022 Altesa BioSciences, a clinical-stage biopharmaceutical company developing novel anti-viral drugs, announced members of its Scientific Advisory Board.See details»

Opportunity - Altesa BioSciences

COPD is the third leading cause of death worldwide, according to the World Health Organization, and it is expected to become the #1 cause of death worldwide within 15 years.See details»

Altesa BioSciences, Inc. - Drug pipelines, Patents, Clinical trials ...

Explore Altesa BioSciences, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 1 news, Disease Domain:Infectious Diseases ...See details»

Altesa BioSciences Recognizes Co-Founder and Partner for Major โ€ฆ

May 25, 2022 Altesa BioSciences recognizes co-founder George Painter, PhD, for major research grant that will establish a new antiviral drug discovery center.See details»

Altesa Biosciences - CipherBio

Explore Altesa Biosciences's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»

Microsoft Word - NR_ALTESA_LAUNCHES_OPS_02.10.2022_final.docx

Feb 10, 2022 1930 Harvard Street, College Park, GA 30337 I Altesabio.com George Painter, PhD, CEO of DRIVE, a discoverer of Molnupiravir and co-founder of Altesa, will serve as Chair โ€ฆSee details»

Altesa BioSciences, Inc., Launches Operations to Develop, โ€ฆ

Feb 10, 2022 ATLANTA-- (BUSINESS WIRE)--Altesa BioSciences, Inc., an independently operated, for-profit biotechnology company today launched operations to develop and โ€ฆSee details»

Altesa BioSciences to Initiate Clinical Trials of Promising ... - BioSpace

May 26, 2022 Altesa BioSciences, Inc. (Altesa), a clinical-stage biopharmaceutical company developing and commercializing novel antiviral drugs against common respiratory viruses and โ€ฆSee details»

Altesa Biosciences Recognizes Co-Founder and Partner for Major โ€ฆ

May 25, 2022 George Painter, Emory Professor and CEO of DRIVE, awarded $52 million to co-lead Antiviral Countermeasures Development Center ATLANTA, May 25, 2022 โ€“ Altesa โ€ฆSee details»

linkstock.net © 2022. All rights reserved